Sub sole [Annotated] (Spanish Edition) by [Lillo, Baldomero] “El ahogado”, “ Irredención”, “En la rueda”, “Las nieves eternas”, “Víspera de difuntos”, “El oro”. En la rueda. 3. Víspera de difuntos. El remolque. 1 other sections not shown. Other editions – View all · Subsole · Baldomero Lillo Limited preview – Santiago de Chile, Imprenta Universitaria Front Cover. Baldomero Lillo Irredencion. Fn la rueda. Las nieves eternas. Víspera de difuntos.
|Published (Last):||25 November 2014|
|PDF File Size:||20.43 Mb|
|ePub File Size:||10.67 Mb|
|Price:||Free* [*Free Regsitration Required]|
The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants.
It is governed by the peer review system and all original papers are subject to internal assessment and external reviews. The journal accepts submissions of articles in English and in Spanish languages. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. CiteScore measures average citations received per document published. SRJ is a prestige metric based on the idea that not all citations are the same.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. The rate of Chronic hepatitis C in dialysis patients is higher than in the general population. The SHECTS study, approved by the Spanish Society of Nephrology, has the goal of analysing the level of examination and follow-up of patients with chronic hepatitis C virus HCV infections on haemodialysis, and to determine the current prevalence of these patients.
A national, multi-centre, cohort study carried out between September and September A total of haemodialysis units 71 hospital-based participated in the study. The global prevalence of HCV was estimated at 5. One-third of all patients received care from a gastroenterologist. Antiviral treatment was administered to The prevalence of HCV in patients on haemodialysis in Spain has decreased to the point of reaching similar rates to those of neighbouring countries.
These patients receive incomplete analyses of liver condition, and individuals who receive antiviral treatment and untreated patients constitute a large proportion, despite having low viral loads and being candidates for kidney transplants. In spite of the evidence that exists on the benefits of antiviral treatment in patients with chronic hepatitis due to HCV and CKD prior to kidney transplant, only some kidney transplant protocol require treatment against HCV and it is not usually catalogued as a transplant prerequisite, but rather a recommendation.
Since there is no medical literature on the level of study and follow-up of chronic hepatitis C in patients on haemodialysis, the need to carry out a cross-sectional study to compile all related aspects, with the aim of detecting improvements in its diagnosis and treatment and assessing the possibility of carrying out a multidisciplinary management between nephrologists and hepatologists.
This folder was sent to all the Nephrology Services and outpatient haemodialysis units in Spain and compiled in the National Nephrology Yearbookpublished by Medibooks, as well as a letter presenting the study, to be completed by a representative researcher from each centre. The folders had to be returned to the postal address of the coordinating centre or the e-mail address of those coordinating the study, to include the data in a central database. The patients had to sign their informed consent to provide their data if the health centre did not have prior authorisation for their use in scientific research.
The study was approved by the Clinical Research and Ethics Committee of the coordinating centre. Researcher evaluation of the questionnaire on the management of their patients with HCV. The data were analysed through the SPSS software version Of the Spanish haemodialysis centres registered in the MediBooks National Yearbook14 had disappeared due to transfer, merger, closure or change of name, with being active: The following participated in the study: The participant percentage per autonomous community is represented in Figure Personal details of the patients.
Data collection folders of patients The mean haemodialysis time was 54 months 4. With respect to kidney transplantation, The characteristics corresponding to the liver situation of the patients is displayed in Table With regard to their personal background, Most patients had a low viral load less thancopies, The patients had undergone the following complementary tests: Analytical, radiological and portal hypertension endoscopic data were found in A third of patients The treatment had a mean duration of 7.
The same patients who were candidates for liver transplant were on the waiting list 1. This study situates the prevalence of chronic hepatitis C in haemodialysis in Spain at 5.
The reduction in the prevalence of HCV in haemodialysis in Spain since may be due to various reasons. In addition, the preventive measures carried out by the Spanish Nephrology Society may have contributed to decreasing contagion, since most centres throughout the decade from to have adopted some isolation measures.
In spite of the attempts to concentrate HCV-positive patients in specific units, Unlike HCV-negative patients, who display high blood pressure and diabetes as causes of their CKD, patients with chronic hepatitis C more commonly have a glomerulonephritis aetiology in The haemodialysis period is long a median of 54 monthswith a very wide range one month to 32 yearswhich helps to understand the higher likelihood of infection since there is longer exposure, as well as a better indication of anti-viral treatment because of a longer life expectancy.
The high percentage of patients not requiring anticoagulation during analysis without being anticoagulated Although the number of candidates for kidney transplant is high, less than half are included on the waiting list.
As with HCV-negative patients, the use of temporary and tunnelled catheters is high and in many cases occurs in subjects selected for arteriovenous fistula, which they currently bear HCV-positive patients display factors forecasting good response to antiviral treatment, such as low viral load Nevertheless, it is striking that only Likewise, Gastrointestinal System Service follow-up is low It is striking that The high assessment of nephrologists about the usefulness of the questionnaire This study is the first on a worldwide scale that assesses the level of study and follow-up of HCV-positive patients in renal replacement therapy with haemodialysis.
It highlights the scarcity of the study of patients with liver disease due to HCV in haemodialysis and, as a result, their insufficient follow-up. It also demonstrates that there is a considerable group of infected patients who qualify for antiviral treatment, which would avoid complications secondary to liver disease, would decrease post-transplant kidney complications and would reduce the risk of HCV contagion in a Haemodialysis Unit.
Obras ─ Colección de Baldomero Lillo
It would be necessary to establish joint management protocols for patients with chronic HCV infection on haemodialysis, with the participation both of nephrologists and of hepatologists. The authors laa that they have no conflicts of interest related to the contents of this article. The results presented in this study have not been sent to be published or been published before in their entirety or in a large part, except as a poster, summary, scientific meeting presentation or register of clinical trials, in which case the reference is given: The importance of the study of liver disease due to HCV in patients on haemodialysis.
Kidney situation of HCV-positive patients on haemodialysis.
Map of Spain with the participation of haemodialysis centres by autonomous community. Home Articles in press Archive.
Previous article Next article. March Pages This item has received. Show more Show less. These patients receive incomplete analyses of liver condition, and individuals who receive antiviral treatment and untreated patients constitute reda large proportion, despite having low viral loads ruueda being candidates for kidney transplants.
The folders had to be returned to the postal address of the coordinating centre or the e-mail address of those coordinating the study, to include the data in a central database. The patients had to sign their informed consent to provide their data if the health centre did not have prior authorisation for their use in scientific research. The study was approved by the Clinical Research and Ethics Committee of the coordinating centre.
Ej study took place from September to September Personal details of the patient: The participant percentage per autonomous community is represented in Figure 1.
Sub sole – Baldomero Lillo – Google Books
It also demonstrates that there is a considerable group of infected patients who qualify for antiviral treatment, which ruedaa avoid complications secondary to liver disease, would decrease post-transplant kidney complications baldkmero would reduce the risk of HCV contagion in a Haemodialysis Unit. It would be necessary to establish joint management protocols for patients with chronic HCV infection on haemodialysis, with the participation both of nephrologists and of hepatologists.
Braun Avitum Canarias, S. Subscribe to our Newsletter. Print Send to a friend Export reference Mendeley Statistics. The anaemia control model: Does it help nephrologists in Role of pyrophosphate in vascular calcification in chronic Testosterone deficiency in dialysis patients: This work is licensed rufda a Creative Commons Attribution 4.
Si continua navegando, consideramos que acepta su uso.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or baldomreo more information by clicking here. Are you a health professional able to prescribe or dispense drugs?